As regulatory expectations and patient engagement strategies evolve, life sciences organizations are rethinking how product information is created, delivered, and consumed. This abstract presents a case in collaboration with the Pharma Ledger Association using Artificial Intelligence (AI) and blockchain to transform traditional drug labeling into structured, digital content—enhancing both operational efficiency and patient access.
Learning Objectives:
Learn how AI and blockchain transform drug labeling into structured, digital content, improving efficiency and patient access. Explore real-world success, hear from a patient impacted by these innovations, and understand how Pharma Ledger enhances PVA, empowers patients, and improves outcomes.
